Username Password
S&P 500: 1,351.68 Change: +0.14%

ZGEN (ZGEN)

Overview
Price 0.00
Price Change Today 0.00 (0.00%)
P&P rating Rating: 0
Open Price $0.00
Previous Close $0.00
Daily Range
52-Week Range
Volume 0
chart
Other Resources for ZGEN
zacks.com
Commentary
Zacks Blog: Concur Joins Cloud Network
May 12, 2011
NetSuite, Inc. is the leading provider of on-demand, integrated business management software for growing and midsize businesses. With thousands of customers globally using NetSuite's online products and professional services, companies are enabled to manage all key business operations in a single hosted system, including: customer relationship management; order fulfillment; inventory; accounting and finance, product assembly; ecommerce; Web site management; and employee productivity.
 
Brokerage Analyst Recommendations
20 Brokerage Firms Covering N
 
    
Strong Buy
4
Buy
2
Hold
13
Sell
0
Strong Sell
1
Average Broker Recommendation (ABR): 2.55
 
N Ratings:BUY  SELL  HOLD
Consensus Forecasts
Rate this Stock!
You haven't rated this stock yet!

What The Community Thinks

Total Players

0 Buy
0 Sell
 
Top Buy Analysis
No Buy Analysis. Be the First.

Top Sell Analysis
No Sell Analysis. Be the First.
Blog Posts
User User Score Date Title Comments Last Comment
franklinqq
0.00 11/30/09 DYAX—Will It be the Next 10x Myth? 0
Zacks_Analysts
0.00 10/11/10 Bristol-Zymo Deal Nears Completion - Analyst Blog 0
Zacks_Analysts
0.00 10/04/10 Bristol Myers at Neutral - Analyst Blog 0
Zacks_Analysts
0.00 09/30/10 ZGEN's Cancer Candidate Encourages - Analyst Blog 0
Zacks_Analysts
0.00 09/29/10 BMY, ZGEN Deal Nears Conclusion - Analyst Blog 0
Zacks_Analysts
0.00 09/09/10 Zacks Analyst Blog Highlights: Bristol-Myers Squibb, ZymoGenetics, Family Dollar Stores, Wal-Mart Stores and Dollar General Corporation - Press Releases 0
Zacks_Analysts
0.00 09/08/10 BMY to Acquire ZymoGenetics - Analyst Blog 0
Zacks_Analysts
0.00 08/27/10 ZGEN's HCV Candidate Progresses - Analyst Blog 0
Zacks_Analysts
0.00 08/09/10 Skelaxin Generics Hit King Pharma - Analyst Blog 0
Zacks_Analysts
0.00 06/04/10 ZymoGenetics Commences Study - Analyst Blog 0
Pages: [ 1 ]  2   3  >>
Commentary
There are no open picks with this stock at the moment.
Picks
There are no open picks with this stock at the moment.
Sponsored Links